Paul Kussie

6.6k total citations · 1 hit paper
47 papers, 3.5k citations indexed

About

Paul Kussie is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Paul Kussie has authored 47 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Paul Kussie's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Proteoglycans and glycosaminoglycans research (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Paul Kussie is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Proteoglycans and glycosaminoglycans research (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Paul Kussie collaborates with scholars based in United States, Canada and Japan. Paul Kussie's co-authors include Shiqing Li, Kathryn M. Ferguson, Philip D. Jeffrey, J.J.W. Wiltzius, Karl R. Schmitz, Peter Böhlen, Elizabeth Navarro, Dale L. Ludwig, Zhenping Zhu and Chonghui Cheng and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Circulation.

In The Last Decade

Paul Kussie

47 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

2005 864 citations Shiqing Li, Philip D. Jeffrey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Kussie United States	30	2.1k	1.1k	695	649	441	47	3.5k
Gert Rijksen Netherlands	32	2.7k 1.3×	1.2k 1.1×	248 0.4×	713 1.1×	626 1.4×	151	4.2k
Anne W. Hamburger United States	29	2.7k 1.3×	2.2k 2.0×	515 0.7×	282 0.4×	764 1.7×	110	4.9k
Norma O’Donovan Ireland	36	2.2k 1.1×	2.3k 2.1×	561 0.8×	205 0.3×	838 1.9×	116	4.3k
Gerhard Siemeister Germany	32	2.2k 1.1×	959 0.9×	176 0.3×	488 0.8×	594 1.3×	68	3.3k
Ralf Brandt United States	18	1.9k 0.9×	2.5k 2.3×	632 0.9×	329 0.5×	381 0.9×	27	4.0k
Mary A. Davis United States	36	1.9k 0.9×	1.7k 1.6×	647 0.9×	171 0.3×	501 1.1×	89	3.9k
Monica R. Maiello Italy	23	2.4k 1.1×	2.2k 2.0×	546 0.8×	227 0.3×	775 1.8×	40	4.4k
Stephan Ruetz Switzerland	23	1.7k 0.8×	2.0k 1.8×	273 0.4×	201 0.3×	272 0.6×	36	3.5k
Donna Headlee United States	24	1.5k 0.7×	1.1k 1.0×	220 0.3×	259 0.4×	328 0.7×	34	2.7k
Jacek Pinski United States	31	1.1k 0.5×	727 0.7×	359 0.5×	258 0.4×	415 0.9×	114	2.9k

Countries citing papers authored by Paul Kussie

Since Specialization

Citations

This map shows the geographic impact of Paul Kussie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Kussie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Kussie more than expected).

Fields of papers citing papers by Paul Kussie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Kussie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Kussie. The network helps show where Paul Kussie may publish in the future.

Co-authorship network of co-authors of Paul Kussie

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Kussie. A scholar is included among the top collaborators of Paul Kussie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Kussie. Paul Kussie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reed, Guy L., Paul Kussie, Karen Lee, et al.. (2016). Abstract 14994: Inactivation of α2-Antiplasmin Promotes Thrombus Dissolution in Humans: Preliminary Results of the Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial. Circulation. 134. 1 indexed citations

Franklin, Matthew C., Elizabeth Navarro, Yujie Wang, et al.. (2011). The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies. Structure. 19(8). 1097–1107. 44 indexed citations

Tuma, M. Carolina, Asra Malikzay, Xiaohu Ouyang, et al.. (2010). Antitumor Activity of IMC-038525, a Novel Oral Tubulin. Translational Oncology. 3(5). 318–325. 28 indexed citations

Li, Shiqing, Paul Kussie, & Kathryn M. Ferguson. (2008). Structural Basis for EGF Receptor Inhibition by the Therapeutic Antibody IMC-11F8. Structure. 16(2). 216–227. 95 indexed citations

Duncton, Matthew A. J., Eugene L. Piatnitski Chekler, Wai C. Wong, et al.. (2008). Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2. Bioorganic & Medicinal Chemistry. 17(2). 731–740. 34 indexed citations

Zhu, Zhenping, Elizabeth Navarro, Paul Kussie, Hu Liu, & Hua‐Quan Miao. (2006). Development of Heparanase Inhibitors for Anti-Cancer Therapy. Current Medicinal Chemistry. 13(18). 2101–2111. 88 indexed citations

Karajannis, Matthias A., Loı̈c Vincent, Sergey V. Shmelkov, et al.. (2006). Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells. Leukemia. 20(6). 979–986. 46 indexed citations

Miao, Hua‐Quan, Weitao Pan, Elizabeth Navarro, et al.. (2005). N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 404–408. 39 indexed citations

Pan, Weitao, Hu Liu, Yong‐Jiang Xu, et al.. (2005). Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases. Bioorganic & Medicinal Chemistry Letters. 15(24). 5474–5477. 18 indexed citations

10.

Wu, Yan, Zhaojing Zhong, Huiling Li, et al.. (2004). A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers. Cancer Research. 64. 694–695. 1 indexed citations

11.

Kelly, Thomas J., Hua‐Quan Miao, Yang Yang, et al.. (2003). High heparanase activity in multiple myeloma is associated with elevated microvessel density.. PubMed. 63(24). 8749–56. 146 indexed citations

12.

Liao, Fang, Jacqueline Doody, Jay Overholser, et al.. (2002). Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.. PubMed. 62(9). 2567–75. 86 indexed citations

13.

Lü, Dan, Paul Kussie, Bronislaw Pytowski, et al.. (2000). Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies. Journal of Biological Chemistry. 275(19). 14321–14330. 59 indexed citations

14.

Kussie, Paul, Jeffrey D. Hulmes, Dale L. Ludwig, et al.. (1999). Cloning and Functional Expression of a Human Heparanase Gene. Biochemical and Biophysical Research Communications. 261(1). 183–187. 170 indexed citations

15.

Cheng, Chonghui, Paul Kussie, Nikola P. Pavletich, & Stewart Shuman. (1998). Conservation of Structure and Mechanism between Eukaryotic Topoisomerase I and Site-Specific Recombinases. Cell. 92(6). 841–850. 202 indexed citations

16.

Wang, Suke, Paul Kussie, Liping Deng, & Alan R. Tall. (1995). Defective Binding of Neutral Lipids by a Carboxyl-terminal Deletion Mutant of Cholesteryl Ester Transfer Protein. Journal of Biological Chemistry. 270(2). 612–618. 39 indexed citations

17.

Jeffrey, Philip D., Joel F. Schildbach, ChiehYing Y. Chang, et al.. (1995). Structure and specificity of the anti-digoxinantibody 40–50. Journal of Molecular Biology. 248(2). 344–360. 56 indexed citations

18.

Takahashi, Kazuo, Xian‐Cheng Jiang, Naohiko Sakai, et al.. (1993). A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.. Journal of Clinical Investigation. 92(4). 2060–2064. 112 indexed citations

19.

Panka, D J, Bruce A. Jacobson, Paul Kussie, et al.. (1993). Defining the structural correlates responsible for loss of arsonate affinity in an IdCR antibody isolated from an autoimmune mouse. Molecular Immunology. 30(11). 1013–1020. 2 indexed citations

20.

Karadsheh, Naif S., Paul Kussie, & D. Scott Linthicum. (1991). Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives. Toxicology Letters. 55(3). 335–342. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact